Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

By protecting both the implants and the patient’s anatomy, we can reduce complications and achieve better outcomes in spinal fusion surgery.” Neo’s co-founder and CEO, Vincent Lefauconnier, said: “The ...

As a Dynamo user, I want to install a package that I know will work for my specific environment. the loading sequence is determined by package loading sequence from Preferences Downloading the same ...

Using advanced microscopy and imaging techniques, scientists have revealed new parts of the human body and overturned previous misconceptions.